Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMM 124-E for Severe Alcoholic Hepatitis (TREAT)
NCT01968382Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Dec 2014
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 2 trial of IMM-124E in alcoholic hepatitis (AH), sponsored by Virginia Commonwealth University. Started Dec 2014; status: completed.
02
Drugs
IMM-124E
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT01968382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968382.